Geoff Considine, Ph.D's Comment & Analysis
A complete archive of Geoff Considine, Ph.D's articles, including current analysis & opinion - Page 4
XOM has surged with inflation and Russia-Ukraine tensions
Dividend yield is 4.4%, but its growth rate is low
Wall Street consensus outlook is mixed
The market-implied outlook (calculated from options...
Manulife reported Q4 2021 and full-year results Feb. 9
MFC’s Wealth and Asset Management business turned in strong results
The Wall Street consensus outlook is bullish
The market-implied outlook...
ABBV faces a significant loss of revenue beginning in 2023 from Humira biosimilars
For now, the company is turning in steady earnings growth
Wall Street consensus outlook is bullish, but with only 3%...
CAT earnings have returned to pre-COVID levels
Valuation is considerably higher than before the pandemic
Wall Street consensus outlook is bullish
Market-implied outlook (calculated from options...
Kinder Morgan provides substantial income, albeit with little expected appreciation
Shares are 21% below their pre-COVID 2020 high
Wall Street analyst outlook is neutral
The market-implied outlook is...
Bristol-Myers Squibb recently reported Q4 earnings, narrowly beating expected EPS
The shares have been volatile over the past 12 months
Wall Street consensus outlook for the next 12 months is...
Bank of Montreal is the eighth largest bank in North America by assets
BMO is acquiring Bank of the West to expand its US presence
Dividend raised by 25% in 2021
Wall Street consensus outlook is...
Cisco is refocusing to compete in a cloud-driven world
The company’s growth aspirations depend on a service-based model
The Wall Street consensus outlook is bullish
The market-implied outlook is...
SBUX has declined almost 18% YTD
Shares have beaten EPS expectations for the past 5 quarters
The Wall Street consensus outlook is bullish
The market-implied outlook (derived from options prices) is...
Nike has had a volatile year and the shares are down 11.8% YTD
The valuation is high
Wall Street consensus is bullish, with about 25% expected 12-month gain
The market-implied outlook for NKE is...